Works matching IS 00070920 AND DT 2014 AND VI 111 AND IP 1

Results: 51
    1
    2
    3
    4
    5
    6
    7

    Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial.

    Published in:
    British Journal of Cancer, 2014, v. 111, n. 1, p. 17, doi. 10.1038/bjc.2014.211
    By:
    • Le Tourneau, C;
    • Paoletti, X;
    • Servant, N;
    • Bièche, I;
    • Gentien, D;
    • Rio Frio, T;
    • Vincent-Salomon, A;
    • Servois, V;
    • Romejon, J;
    • Mariani, O;
    • Bernard, V;
    • Huppe, P;
    • Pierron, G;
    • Mulot, F;
    • Callens, C;
    • Wong, J;
    • Mauborgne, C;
    • Rouleau, E;
    • Reyes, C;
    • Henry, E
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50